Colon TumorMACS™ Medium, human

Colon TumorMACS Medium is an optimized serum-free cell culture medium for the cultivation and expansion of tumor cells from primary and xenotransplanted colorectal tumors. It enables the establishment of new cell lines from freshly dissociated tumor tissue.

The medium supports the transition of tumor cells into physiologically relevant 3D culture formats, including tumor organoids and tumoroids.

Related products for Colon TumorMACS™ Medium, human

Specifications for Colon TumorMACS™ Medium, human
Overview

Colon TumorMACS Medium is an optimized serum-free cell culture medium for the cultivation and expansion of tumor cells from primary and xenotransplanted colorectal tumors. It enables the establishment of new cell lines from freshly dissociated tumor tissue.

The medium supports the transition of tumor cells into physiologically relevant 3D culture formats, including tumor organoids and tumoroids.

Detailed product information
Background information

The Colon TumorMACS Medium is an optimized and standardized medium for the reliable expansion of tumor cells from primary or xenotransplanted human colorectal tumor samples. Tumor cells from freshly dissociated tissue can be cultured over multiple passages, allowing for in vitro assays, such as drug screenings on primary cell cultures or characterization studies including gene expression or protein profiling. In addition, the Colon TumorMACS Medium supports the establishment of new cell lines and thereby obtaining sufficient cell numbers for further experiments, such as in vivo transplantation studies in animals. Colon TumorMACS Medium efficiently expands cultures of primary colorectal tumor cells in vitro while maintaining the cell populations' heterogeneity and tumorigenic potential. The medium is manufactured under strictly controlled conditions using ingredients of the highest quality. Colon TumorMACS Medium offers consistent lot-to-lot performance and optimal conditions for the cultivation of primary colorectal tumor cells.

Citations for Colon TumorMACS™ Medium, human
Publications
  1. D'Angelo, E. et al. (2025) Tumor microenvironment-mimicking macrophage nanovesicles as a targeted therapy platform for colorectal cancer. Int. J. Oncol. 10 (670)
  2. Agorku, D. J. et al. (2024) Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Cancer Lett. 595: 216985

You have previously chosen International as your location.
What do you want to do?